CING CIK: 1862150

Cingulate Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.4
FY22:
−15.9
FY23:
−15.0
FY24:
−18.5
FY25:
−17.2
Change from FY21 to FY25
millions USD
FY21:
−0.81
FY22:
−0.15
FY23:
−0.22
FY24:
−0.21
FY25:
−0.16
Change from FY21 to FY25
millions USD
FY21:
26.5
FY22:
4.90
FY23:
9.95
FY24:
30.8
FY25:
16.1
millions USD
FY21:
15.3
FY22:
−11.1
FY23:
−5.30
FY24:
12.2
FY25:
−1.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.2
FY22:
−16.0
FY23:
−15.3
FY24:
−18.7
FY25:
−17.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data